Skip to content
Tech News
← Back to articles

Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

read original get Omicron Variant Face Mask → more articles
Why This Matters

This correction highlights important findings about the Omicron variant's reduced fusogenicity and pathogenicity, which could influence future vaccine development and public health strategies. Understanding these changes helps the tech industry, especially in biotech and health tech sectors, develop more effective diagnostic tools and treatments. It also reassures consumers about the evolving nature of the virus and ongoing scientific efforts to combat COVID-19.

Key Takeaways

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions